Literature DB >> 22665927

Positioning accuracy for lung stereotactic body radiotherapy patients determined by on-treatment cone-beam CT imaging.

N D Richmond1, K E Pilling, C Peedell, D Shakespeare, C P Walker.   

Abstract

Stereotactic body radiotherapy for early stage non-small cell lung cancer is an emerging treatment option in the UK. Since relatively few high-dose ablative fractions are delivered to a small target volume, the consequences of a geometric miss are potentially severe. This paper presents the results of treatment delivery set-up data collected using Elekta Synergy (Elekta, Crawley, UK) cone-beam CT imaging for 17 patients immobilised using the Bodyfix system (Medical Intelligence, Schwabmuenchen, Germany). Images were acquired on the linear accelerator at initial patient treatment set-up, following any position correction adjustments, and post-treatment. These were matched to the localisation CT scan using the Elekta XVI software. In total, 71 fractions were analysed for patient set-up errors. The mean vector error at initial set-up was calculated as 5.3 ± 2.7 mm, which was significantly reduced to 1.4 ± 0.7 mm following image guided correction. Post-treatment the corresponding value was 2.1 ± 1.2 mm. The use of the Bodyfix abdominal compression plate on 5 patients to reduce the range of tumour excursion during respiration produced mean longitudinal set-up corrections of -4.4 ± 4.5 mm compared with -0.7 ± 2.6 mm without compression for the remaining 12 patients. The use of abdominal compression led to a greater variation in set-up errors and a shift in the mean value.

Entities:  

Mesh:

Year:  2012        PMID: 22665927      PMCID: PMC3474122          DOI: 10.1259/bjr/54341099

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  7 in total

1.  The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy.

Authors:  M van Herk; P Remeijer; C Rasch; J V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-07-01       Impact factor: 7.038

Review 2.  Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).

Authors:  N P Rowell; C J Williams
Journal:  Cochrane Database Syst Rev       Date:  2001

3.  Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.

Authors:  Yasushi Nagata; Kenji Takayama; Yukinori Matsuo; Yoshiki Norihisa; Takashi Mizowaki; Takashi Sakamoto; Masato Sakamoto; Michihide Mitsumori; Keiko Shibuya; Norio Araki; Shinsuke Yano; Masahiro Hiraoka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-19       Impact factor: 7.038

4.  Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance.

Authors:  Jan-Jakob Sonke; Maddalena Rossi; Jochem Wolthaus; Marcel van Herk; Eugene Damen; Jose Belderbos
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-27       Impact factor: 7.038

5.  Image-guided radiotherapy via daily online cone-beam CT substantially reduces margin requirements for stereotactic lung radiotherapy.

Authors:  Inga S Grills; Geoffrey Hugo; Larry L Kestin; Ana Paula Galerani; K Kenneth Chao; Jennifer Wloch; Di Yan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-29       Impact factor: 7.038

6.  Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer.

Authors:  Robert Timmerman; Lech Papiez; Ronald McGarry; Laura Likes; Colleen DesRosiers; Stephanie Frost; Mark Williams
Journal:  Chest       Date:  2003-11       Impact factor: 9.410

Review 7.  Current surgical treatment of nonsmall cell lung cancer 2001.

Authors:  J Deslauriers
Journal:  Eur Respir J Suppl       Date:  2002-02
  7 in total
  8 in total

1.  Increasing frequency of reirradiation studies in radiation oncology: systematic review of highly cited articles.

Authors:  Carsten Nieder; Nicolaus H Andratschke; Anca L Grosu
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

2.  Feasibility study of automated framework for estimating lung tumor locations for target-based patient positioning in stereotactic body radiotherapy.

Authors:  Satoshi Yoshidome; Hidetaka Arimura; Katsumasa Nakamura; Yoshiyuki Shioyama; Kazushige Atsumi; Yasuhiko Nakamura; Hideki Yoshikawa; Kei Nishikawa; Hideki Hirata
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

3.  Development of a novel low-radiation-absorbent lok-bar to reduce X-ray scattering and absorption in RapidArc® treatment planning and dose delivery.

Authors:  Hajime Monzen; Kazuki Kubo; Mikoto Tamura; Masaru Hayakawa; Yasumasa Nishimura
Journal:  J Appl Clin Med Phys       Date:  2017-04-06       Impact factor: 2.102

4.  Choice of immobilization of stereotactic body radiotherapy in lung tumor patient by BMI.

Authors:  Guofu Chen; Baiqiang Dong; Guoping Shan; Xiuqin Zhang; Huarong Tang; Yuchen Li; Zhenhua Wang; Wei Xu; Gang Xu; Guiming Yan; Feiyan Zhang; Xiao Hu; Jun Yang; Yujin Xu; Ming Chen; Jin Wang
Journal:  BMC Cancer       Date:  2019-06-14       Impact factor: 4.430

5.  Robust Optimization of SBRT Planning for Patients With Early Stage Non-Small Cell Lung Cancer.

Authors:  Haijiao Shang; Yuehu Pu; Yuenan Wang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

6.  CT Appearance Pattern After Stereotactic Body Radiation Therapy Predicts Outcomes in Early-Stage Non-Small-Cell Lung Cancer.

Authors:  Yan Yang; Gaohua Li; Shuyuan Li; Yuanhang Wang; Yanbo Zhao; Baiqiang Dong; Jin Wang; Ruiwu Zhu; Ming Chen
Journal:  Front Oncol       Date:  2021-10-11       Impact factor: 6.244

7.  Comparative analysis of thermoplastic masks versus vacuum cushions in stereotactic body radiotherapy.

Authors:  Arturo Navarro-Martin; Jon Cacicedo; Olwen Leaman; Ismael Sancho; Elvira García; Valentin Navarro; Ferran Guedea
Journal:  Radiat Oncol       Date:  2015-08-20       Impact factor: 3.481

8.  Lung tumor motion reproducibility for five patients who received four-fraction VMAT stereotactic ablative body radiotherapy under constrained breathing conditions: a preliminary study.

Authors:  Keiichi Nakagawa; Akihiro Haga; Katsutake Sasaki; Satoshi Kida; Yoshitaka Masutani; Hideomi Yamashita; Wataru Takahashi; Hiroshi Igaki; Akira Sakumi; Kuni Ohtomo; Kiyoshi Yoda
Journal:  J Radiat Res       Date:  2014-06-25       Impact factor: 2.724

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.